Trial intelligence / Profile preview

Tafenoquine vs Mefloquine for Malaria Prophylaxis in Kenya

NCT02488980Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
May 2000
Primary completion
Oct 2000
Modality
Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01

Overview

A Phase 2 trial of tafenoquine in Plasmodium falciparum malaria, sponsored by U.S. Army Medical Research and Development Command. Started May 2000; status: completed.

02

Drugs

tafenoquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT02488980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02488980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call